Rapport Therapeutics, Inc. RAPP 深 滬
等待開盤 10-16 09:30:00 美东时间
25.78
+0.900
+3.62%
華盛通- 最 高26.545
- 今 開25.29
- 成交量 45.08万股
- 最 低 25.17
- 昨 收 24.88
- 總市值 11.89亿
- 52周最高 42.2685
- 市盈率 靜 --
- 換手率 0.98%
- 52周最低 6.43
- 委 比 -10.38%
- 總股本 4611.31万
- 歷史最高 42.2685
- 量 比 0.99
- 振 幅 5.53%
- 歷史最低 6.43
- 每 手 1
- 風險率 6.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
09-17 10:15
Rapport assigned a new Buy at Truist on lead program
Rapport Therapeutics (NASDAQ:RAPP) traded higher on Tuesday after Truist launched its coverage with a Buy recommendation and a $44 price target, citing the neuro drug developer’s lead candidate RAP-21...
09-17 02:28
Analysts Are Bullish on Top NA Stocks: Rubrik, Inc. Class A (RBRK), Rapport Therapeutics, Inc. (RAPP)
There’s a lot to be optimistic about in the NA sector as 2 analysts just weighe...
09-12 17:30
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Rapport Therapeutics announced that its management will participate in TD Cowen’s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit on September 17, 2025. The company, focused on developing precision medicines for neurological and psychiatric disorders, will host a fireside chat during the virtual event. Investors can access the webcast on the company’s website. Rapport’s RAP technology platform enables the creation of targeted sma...
09-11 20:05
生物制药公司Rapport重挫18.8%，此前完成2.5亿美元的公开发行
美股周三早盘，专注于中枢神经系统（CNS）疾病创新疗法研发的生物制药公司Rapport Therapeutics（RAPP）股价重挫18.8%，此前该公司以...
09-10 22:54
Rapport Therapeutics prices $250M stock at $26 per share
Rapport Therapeutics (NASDAQ:RAPP) priced an underwritten public offering of 9.62M shares at a public offering price of $26.00 per share. The underwriters have a 30-day option to purchase up to an add...
09-10 15:30
美股牛股 | 大涨超120%！RAPP新药试验迎进展；房多多涨超47%，政策面迎利好
大涨超120%！RAPP新药试验迎进展；房多多涨超47%，深圳楼市政策调整释放利好；PL绩后大涨近48%>>
09-09 16:51
Rapport Therapeutics Terminates Common Stock Prospectus
Rapport Therapeutics, Inc. ( ($RAPP) ) has shared an announcement. On September...
09-09 04:39
SA analyst upgrades/downgrades: TSLA, NVDA, MDB, and MAR
MongoDB (NASDAQ:MDB) received a significant upgrade following impressive Q2 earnings that delivered a 49% EPS surprise, suggesting the company is successfully positioning itself as a leader in AI appl...
09-09 00:56
Rapport Announces Proposed Public Offering of Common Stock
Rapport Therapeutics is conducting a $250 million underwritten public offering of its common stock, with an option for underwriters to purchase an additional $37.5 million. The offering is subject to market conditions and has been filed with the SEC under a shelf registration statement. Rapport Therapeutics focuses on developing small molecule precision medicines for neurological and psychiatric disorders, utilizing its RAP technology platform to...
09-08 20:05
